Indapamide and Amlodipine are two medications commonly used in combination to treat hypertension (high blood pressure). Indapamide is a thiazide-like diuretic that helps reduce fluid retention and lower blood pressure by increasing urine production. Amlodipine is a calcium channel blocker that relaxes the blood vessels, improving blood flow and further lowering blood pressure. The combination of these drugs is effective for patients who require multiple mechanisms to control their hypertension.
Indapamide and Amlodipine are primarily used to manage:
| Brand Name | Indapamide + Amlodipine |
|---|---|
| Type | |
| Weight | |
| Generic | Indapamide + Amlodipine |
| Manufacturer | |
| Available in | English বাংলা |
Indapamide acts by inhibiting sodium reabsorption in the kidneys, leading to increased excretion of sodium and water, which lowers blood volume and decreases blood pressure. Amlodipine, a calcium channel blocker, works by inhibiting the influx of calcium ions into vascular smooth muscle cells, causing vasodilation and reducing peripheral resistance. Together, these actions synergistically lower blood pressure and reduce the workload on the heart.
Indapamide begins to take effect within 1-2 hours of oral administration, with peak diuretic effects occurring within 6 hours. Amlodipine takes 6-12 hours to reach peak plasma concentrations after administration. However, it may take up to 1-2 weeks for the full antihypertensive effects of the combination therapy to be noticeable.
Indapamide is well absorbed after oral administration, with approximately 93% bioavailability. Amlodipine is also well absorbed, with an oral bioavailability of 60-90%. Both drugs have prolonged half-lives, allowing for once-daily dosing.
Indapamide is primarily metabolized by the liver and its metabolites, along with a small amount of unchanged drug, are excreted via urine. Amlodipine is extensively metabolized in the liver and its metabolites are excreted via urine and feces.
The typical dosages for Indapamide and Amlodipine in combination therapy are as follows:
Indapamide and Amlodipine are administered orally, usually once daily. The tablets can be taken with or without food. Consistency in the timing of doses is recommended for optimal blood pressure control.
Common side effects of the Indapamide and Amlodipine combination may include:
In cases of overdose, Indapamide may cause excessive diuresis, leading to dehydration, hypotension, and electrolyte imbalances (especially hypokalemia). Amlodipine overdose may result in severe hypotension, bradycardia, or even cardiogenic shock. Immediate medical intervention is required in cases of overdose.
Use caution in patients with liver or kidney impairment, as both drugs are metabolized by the liver and/or excreted by the kidneys. Monitoring of blood electrolytes (especially potassium levels) is essential during treatment due to the risk of hypokalemia with Indapamide. Amlodipine should be used cautiously in patients with severe aortic stenosis or heart failure.
Indapamide and Amlodipine may interact with various medications:
Use with caution in patients with:
Drug interactions may include:
There are no significant food interactions with Indapamide and Amlodipine. However, it is advisable to maintain a low-sodium diet to optimize blood pressure control and avoid excessive fluid retention.
Amlodipine is classified as Pregnancy Category C, meaning that risk to the fetus cannot be ruled out. Indapamide is also not recommended during pregnancy due to the potential risk of harm to the developing fetus. Use should be avoided unless absolutely necessary and prescribed by a healthcare provider.
The use of Indapamide and Amlodipine during lactation should be approached with caution. Both drugs may pass into breast milk, and their effects on the nursing infant are not well-studied. Consult a healthcare provider before use during breastfeeding.
Symptoms of acute overdose with Indapamide include dehydration, electrolyte imbalances, and severe hypotension. Amlodipine overdose may cause pronounced hypotension, bradycardia, and even cardiovascular collapse. Treatment typically involves supportive care, including fluid replacement and monitoring of vital signs. Activated charcoal may be used if the overdose is recent.
The combination of Indapamide and Amlodipine is contraindicated in patients with:
Indapamide and Amlodipine should be taken exactly as prescribed by a healthcare provider. The medication is typically taken once daily, with or without food. Do not stop or change the dosage without consulting a healthcare provider.
Store Indapamide and Amlodipine tablets at room temperature (20-25°C) in a dry place away from moisture and heat. Keep the medication out of reach of children.
The volume of distribution for Amlodipine is approximately 21 L/kg, indicating extensive distribution into tissues. The volume of distribution for Indapamide is around 25 L/kg, reflecting significant tissue penetration.
The half-life of Indapamide is approximately 14-16 hours, allowing for once-daily dosing. Amlodipine has a longer half-life of approximately 30-50 hours, which supports once-daily administration for blood pressure control.
Indapamide is cleared primarily through renal excretion, with a clearance rate of approximately 20 mL/min. Amlodipine is cleared primarily by hepatic metabolism, with an elimination clearance of around 7 mL/min/kg.
See in details version Indapamide + Amlodipine also Indapamide + Amlodipine in bangla